Bio-organoids

Our patient-derived organoids are threedimensional cultures of cells that mimic the structural and functional properties of human organs. They are derived from tissues obtained from individual patients, providing a personalized platform for disease modeling and drug screening. Due to their high similarity to the patient's tissue, patient-derived organoids have the potential to revolutionize precision medicine and accelerate the development of targeted therapies.

Key Advantages

• Human relevant:

  These organoids are derived directly from patient tissue, allowing them to accurately mimic the pathophysiology of the parental organ in vivo.

• Specific tissue of origin:

  These organoids are highly specialized for their specific tissue of origin, such as colon stem cells only producing colon organoids.

• Genetically and phenotypically stable:

  Organoids maintain parental tissue characteristics indefinitely in culture and after cryopreservation, making them suitable for long-term experiments.

• Expandable:

  Organoids can be expanded for large-scale screening, providing a cost-effective and high-throughput tool for drug discovery and screening. Suitable for genetic manipulation and in vitro assays: Organoids can be genetically manipulated and used in standard in vitro assays, allowing researchers to investigate specific cellular processes and pathways. Amenable to in vivo modeling: Organoids can be engrafted or xenotransplanted into animal models, providing a platform for in vivo modeling of diseases and testing of potential therapies.

Products

Our patient-derived organoids are threedimensional cultures of cells that mimic the structural and functional properties of human organs.

CANCER

• BREAST CANCER
• SKIN CANCER
• OVARIAN CANCER
• COLON CANCER
• ORAL CANCER
• PROSTATE CANCER
• LUNG CANCER
• UTERAL CANCER
• BLADDER CANCER

NORMAL

• LIVER
• BRAIN
• LUNG
• PANCREAS
• SPLEEN
• PROSTATE
• KIDNEY
• COLON
• BLADDER